ATRIP and breast carcinoma: Further support for the involvement of ATRIP in hereditary breast cancer predisposition has emerged from a large exome-wide gene burden meta-analysis published in 2025, which examined more than 74,000 breast cancer patients and 748,000 controls across multiple international cohorts, including the Million Women Study, UK Biobank, BCAC, All of Us, MGB, and FinnGen [10].